Company / Profit Margin
Anika Therapeutics, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-9.6%
FY2025
5-year range
-68.4% / 23.7%
FY2021-FY2025
Trend
+79.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 10 years, ranging from -68.4% in FY2023 to 36.3% in FY2016.
Based on SEC 10-K filings.
-9.6% in FY2025 with a 5-year CAGR of -27.4%.
Improved from -68.4% to -9.6% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +8.7pp
- 5-Year Change
- -27.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 79.5% year-over-year.
- Peak profit margin was recorded in FY2016.
- Lowest profit margin in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -9.6% | +79.5% |
| FY2024 | -47.0% | +31.3% |
| FY2023 | -68.4% | -272.4% |
| FY2022 | -18.4% | -177.5% |
| FY2021 | 23.7% | +33.8% |
| FY2020 | 17.7% | -36.8% |
| FY2019 | 28.1% | -10.9% |
| FY2018 | 31.5% | -4.8% |
| FY2017 | 33.1% | -8.9% |
| FY2016 | 36.3% | +32.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026